Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday

Pfizer/BioNTech said they intend to submit applications to other regulatory agencies worldwide in coming days.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.